Item 8.01 Other Events.
On January 6, 2022, Heyu Biological Technology Corporation (the "Company")
issued a press release announcing its receipt of a letter dated December 17,
2021 from the Securities and Exchange Commission notifying the Company of its
non-compliance with its reporting requirements under Section 13(a) of the
Securities Exchange Act of 1934, as amended. The Company has submitted a
response letter to the SEC, requesting an extension of the deadlines for the
Company's missed filings. The Company has been in the process of preparing all
required filings with the assistance of its auditor and outside counsel on an
expedited basis. A copy of the press release is attached hereto as Exhibit 99.1
and is incorporated by reference herein.
Item 9.01 Financial Statements and Exhibits
Number Description of Exhibit
99.1 Press Release, dated January 6, 2022, announcing Heyu Biological
Technology Corporation's receipt of an SEC letter notifying its
non-compliance with reporting obligations
1
© Edgar Online, source Glimpses